Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: XCR2BZ80N7

Pharmacology

Action Mechanism of Action Reference
DISRUPTING AGENT DNA disrupting agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 3 D001943 ClinicalTrials
Endometrial Neoplasms 2 D016889 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298178
FDA SRS XCR2BZ80N7